Prescription Drug Overdose: Boost for State Prevention

Post Date

April 3rd 2014

Application Due Date

June 4th 2014

Funding Opportunity Number

CDC-RFA-CE14-1404

CFDA Number(s)

93.136

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

5

Eligibility Categories

Other

State Departments of Health or their Bona Fide Agents

Funding

• Estimated Total Funding:

  $6000000

• Award Range:

  $0 - $0

Grant Description

The purpose of this funding is to advance and evaluate comprehensive state-level interventions for preventing prescription drug misuse, abuse, and overdose. Interventions of interest address patient and prescriber behaviors that drive the prescription drug overdose epidemic, particularly the misuse and inappropriate prescribing of opioid pain relievers. Specifically, awardees will perform activities that support at least two of the following complementary key prevention strategies to prevent prescription drug misuse, diversion, and overdose: enhancing and maximizing prescription drug monitoring programs (PDMPs); improving and evaluating state health insurance mechanisms to prevent prescription drug misuse, diversion, and overdose (e.g., via Medicaid or workersу compensation); and evaluating state-level laws, policies, and regulations (e.g., legislation regulating pain clinics, or supporting clinical practice guidelines). The primary outcomes of interest may vary by strategy. They might include programmatic outcomes (e.g., mandatory PDMP registration and use, enrollment in patient review and restriction programs), behavior change (e.g., decrease prescribing inconsistent with clinical guidelines, decreased doctor shopping), and/or health-related outcomes (e.g., decrease in emergency department visits due to misuse or abuse of controlled prescription drugs, decreased drug overdose death rate). State-level engagement is critical to the success of this FOA given the concentration of the authority to address the use and misuse of prescription drugs within state government. Multi-sector collaboration with partners that have shared authority over this issue is also needed (e.g., law enforcement, boards of pharmacy, medical boards, mental health and substance abuse services, medical centers, lead state agencies for Medicaid programs.) Applicants are therefore required to submit letters of support from state-level governmental entities and other partners depending on the strategies they pursue under their work plan.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC
  Procurement and Grants Office (PGO)
  Technical Information Management Section (TIMS)
  Phone: 770-488-2700

• Agency Mailing Address:

  Technical Information Management Section (TIMS)

• Agency Email Address:

  pgotim@cdc.gov

• More Information:

  THIS LINK IS NOT AN ACTIVE LINK. CLICK ON рFULL ANNOUNCEMENTс AT THE TOP OF THIS PAGE TO ACTIVATE.